Literature DB >> 9211353

In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy.

D Suzuki1, M Miyazaki, K Jinde, T Koji, M Yagame, M Endoh, Y Nomoto, H Sakai.   

Abstract

Progressive expansion of the mesangial matrix is one of the most characteristic histological features of diabetic nephropathy (DN). To determine the balance between the turnover and degradation of extracellular matrix (ECM) in renal tissue of patients with DN, we examined the expression of matrix metalloproteinase-3 (MMP-3), tissue inhibitor of metalloproteinase-1 (TIMP-1) and type IV collagen (IV-C) mRNAs using a high-resolution in situ hybridization. Patients were divided into three grades: mild (grade I), moderate (grade II) and severe (grade III) mesangial expansion and tubulointerstitial injury. The relationship between the expression of these mRNAs and degree of glomerular mesangial expansion and interstitial injury was also examined. Cells positive for each mRNA were observed in glomerular resident cells, including glomerular mesangial, epithelial and endothelial cells and cells of Bowman's capsule. A number of tubular epithelial cells and some infiltrating cells in the interstitium also expressed these mRNAs. The expression of MMP-3 mRNA and TIMP-1 mRNA was strongest in glomeruli of grade I and inversely correlated with mesangial expansion. In contrast, the expression of all three types of mRNA was correlated with the degree of interstitial injury. Our results indicate that IV-C, MMP-3 and TIMP-1 mRNAs are expressed in glomerular resident cells, tubular epithelial cells and infiltrating cells in renal tissue of DN, and suggest that their expression changes with the degree of mesangial expansion and interstitial injury. Altered expression of MMP-3 and TIMP-1 may be associated with the progression of DN.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9211353     DOI: 10.1038/ki.1997.310

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

1.  Role for macrophage metalloelastase in glomerular basement membrane damage associated with alport syndrome.

Authors:  Velidi H Rao; Daniel T Meehan; Duane Delimont; Motowo Nakajima; Takashi Wada; Michael Ann Gratton; Dominic Cosgrove
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

2.  Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations.

Authors:  M Saghizadeh; D J Brown; R Castellon; M Chwa; G H Huang; J Y Ljubimova; S Rosenberg; K S Spirin; R B Stolitenko; W Adachi; S Kinoshita; G Murphy; L J Windsor; M C Kenney; A V Ljubimov
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy.

Authors:  Makiho Sekiuchi; Akihiko Kudo; Kimimasa Nakabayashi; Masami Kanai-Azuma; Yoshihiro Akimoto; Hayato Kawakami; Akira Yamada
Journal:  Clin Exp Nephrol       Date:  2012-05-22       Impact factor: 2.801

4.  A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy.

Authors:  T Miyata; M Nangaku; D Suzuki; R Inagi; K Uragami; H Sakai; K Okubo; K Kurokawa
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

5.  Matrix Metalloproteinase 20 Co-expression With Dentin Sialophosphoprotein in Human and Monkey Kidneys.

Authors:  Kalu U E Ogbureke; Komal Koli; Geetu Saxena
Journal:  J Histochem Cytochem       Date:  2016-10       Impact factor: 2.479

6.  Production and degradation of extracellular matrix in reversible glomerular lesions in rat model of habu snake venom-induced glomerulonephritis.

Authors:  Tayo Kawazu; Tomoya Nishino; Yoko Obata; Akira Furusu; Masanobu Miyazaki; Katsushige Abe; Takehiko Koji; Shigeru Kohno
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

Review 7.  Soluble biglycan as a biomarker of inflammatory renal diseases.

Authors:  Louise Tzung-Harn Hsieh; Madalina-Viviana Nastase; Jinyang Zeng-Brouwers; Renato V Iozzo; Liliana Schaefer
Journal:  Int J Biochem Cell Biol       Date:  2014-08-01       Impact factor: 5.085

8.  Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria.

Authors:  Shin-ichi Araki; Masakazu Haneda; Daisuke Koya; Keiji Isshiki; Shinji Kume; Toshiro Sugimoto; Hiromichi Kawai; Yoshihiko Nishio; Atsunori Kashiwagi; Takashi Uzu; Hiroshi Maegawa
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 19.112

9.  Effect of all-trans retinoic acid on renal expressions of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with glomerulosclerosis.

Authors:  Yuan-Han Qin; Feng-Ying Lei; Peng Hu; Juan Pei; Zhen-Bo Feng; Yu-Sheng Pang
Journal:  Pediatr Nephrol       Date:  2009-04-09       Impact factor: 3.714

Review 10.  A glimpse of matrix metalloproteinases in diabetic nephropathy.

Authors:  X Xu; L Xiao; P Xiao; S Yang; G Chen; F Liu; Y S Kanwar; L Sun
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.